Rani Therapeutics Holdings (RANI) Income from Non-Controlling Interests (2020 - 2026)
Rani Therapeutics Holdings (RANI) posted Income from Non-Controlling Interests of -$1.03 million for Q2 2026, compared with -$4.53 million a year earlier.
Powered by 
Analysis
Rani Therapeutics Holdings (RANI) Income from Non-Controlling Interests (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income from Non-Controlling Interests at Rani Therapeutics Holdings was -$3.28 million; for FY2025, it was -$11.28 million.
- In prior years, Rani Therapeutics Holdings' Income from Non-Controlling Interests was -$26.57 million in FY2024, -$33.91 million in FY2023, -$32.76 million in FY2022 and -$44.76 million in FY2021.
- Quarterly Income from Non-Controlling Interests has run from a low of -$25.56 million in Q3 2021 to a high of $1.23 million in Q4 2025 over five years.
- According to Business Quant data, Income from Non-Controlling Interests for the three prior quarters was -$982,000 (Q1 2026), $1.23 million (Q4 2025) and -$2.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Rani Therapeutics Holdings | 151.61 Mn | 160.36 Mn | - | -1.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.03 Mn |
| Mar 31, 2026 | -982,000.00 |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | -2.50 Mn |
| Jun 30, 2025 | -4.53 Mn |
| Mar 31, 2025 | -5.47 Mn |
| Dec 31, 2024 | -6.78 Mn |
| Sep 30, 2024 | -5.94 Mn |
| Jun 30, 2024 | -6.56 Mn |
| Mar 31, 2024 | -7.30 Mn |
| Dec 31, 2023 | -6.96 Mn |
| Sep 30, 2023 | -9.14 Mn |
| Jun 30, 2023 | -9.36 Mn |
| Mar 31, 2023 | -8.46 Mn |
| Dec 31, 2022 | -8.56 Mn |
| Sep 30, 2022 | -8.25 Mn |
| Jun 30, 2022 | -8.34 Mn |
| Mar 31, 2022 | -7.61 Mn |
| Dec 31, 2021 | -8.12 Mn |
| Sep 30, 2021 | -25.56 Mn |
API Access
Rani Therapeutics Holdings Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=RANI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "RANI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=RANI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();